About
Jeffrey N. Miner is a biotech R&D executive and scientist associated with 3D tissue technology and multi-omics-driven drug discovery. As of Organovo's June 30, 2022 10-Q, he served as Organovo's Chief Scientific Officer and was also listed as co-founder, Chief Scientific Officer, and a significant stockholder of Viscient Biosciences. By Organovo's April 12, 2024 S-1, he was described as Organovo's former Chief Scientific Officer while remaining Viscient's co-founder and Chief Scientific Officer.
Areas of interest
biotechdrug discovery3D tissue technologymulti-omicspreclinical researchtranslational sciencelongevity